Viewing nowCombinationAmlobika Tablet 5/20mg
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.

MFDS item code 201404737 · Approved 2014.10.15 · Insurance code 649102490
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension is a condition where blood pressure remains continuously high, burdening the cardiovascular system. This medication can be used to effectively lower blood pressure when using amlodipine or olmesartan medoxomil alone is insufficient for blood pressure control. This can help reduce the risk of cardiovascular complications and improve overall health. Patients should consistently take the medication and regularly monitor their blood pressure, and better results can be expected with lifestyle improvements. This drug is used for the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this drug may be considered. The maximum dose of this drug is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg as monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg as monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ○ Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily, and administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○ Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics. This drug should not be administered to patients with severe hepatic impairment. (See section 2, Patients who should not receive this drug, under Precautions for Use.) ○ Older adults: In general, treatment should be initiated at a low dose. When adjusting the dose, the patient's renal or cardiac function and comorbidities should be taken into consideration. Blood pressure should be monitored closely and more frequently in older adults.
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age.
This drug can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the main ingredients or similar class medications, women who are pregnant or nursing, patients with severe liver dysfunction, severe aortic stenosis, obstructive biliary disease, patients on dialysis, those in shock, and certain diabetic patients should not take this medication. When this drug is initially administered to patients who are depleted of fluids or salts, it may cause a significant drop in blood pressure, so careful monitoring of the patient's condition is required, and appropriate measures should be taken if necessary. Acute hypotension may occur after taking this medication due to vasodilation, so patients with severe aortic stenosis should use caution. Use this medication cautiously in patients with severe heart disease or congestive heart failure, and those with impaired renal function should also be careful. Patients with impaired liver function may experience slower metabolism of this drug and should use caution while taking it. Side effects such as dizziness, headaches, low blood pressure, cough, digestive disorders, skin rashes, etc., might occur. If unusual symptoms appear, consult a doctor. In particular, women who are pregnant or planning to become pregnant should switch to other established safe antihypertensives, and if this drug was taken during pregnancy, tests are needed to check for any fetal abnormalities. Breastfeeding women are advised to discontinue breastfeeding or stop taking the medication since it may be transmitted through breast milk. Safety and efficacy have not been established for children or adolescents, so it is not recommended for them. In elderly patients, dose adjustments should be made considering the decline of liver and kidney functions, and they should take it cautiously. In case of overdose, symptoms may appear due to low blood pressure and excessive vasodilation, requiring immediate medical attention, and blood pressure and heart function should be closely monitored. Taking this medication with grapefruit juice may increase its blood pressure-lowering effect; therefore, it is advisable to avoid it, and interactions with other drugs should be discussed with a physician or pharmacist. Store this medication in a sealed container to protect it from air and moisture. It should be kept out of the reach of children and stored away from direct sunlight.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container protected from air and moisture. It is recommended to keep the storage temperature between 1°C and 30°C at room temperature. Proper storage like this can help maintain the drug's effectiveness for a longer period.
White round film-coated tablet
30 tablets (10 tablets / PTP packaging x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.